BRIEF-Leaf Resources updates on trading halt

* Trading halt is requested pending respect to proposed

placements of shares

Source text for Eikon:

Further company coverage:

Read more

BRIEF-CSL upgrades NPAT expectation for FY2017

* Upgraded its net profit after tax (NPAT) expectation for

FY2017

Read more

BRIEF-venBio sends letter to Immunomedics stockholders

* Beneficial owner of about 10.5 million shares, or 9.9%, of

Immunomedics Inc and its largest stockholder

Read more

FTC, states settle with Mallinckrodt over Acthar

WASHINGTON, Jan 18 (Reuters) - Mallinckrodt Plc,

which bought Questcor Pharmaceuticals in 2014, has agreed to pay

$100 million to settle allegations that Questcor broke antitrust

law in pricing its multiple sclerosis drug H.P. Acthar Gel, the

Federal Trade Commission said on Wednesday.

(Reporting by Diane Bartz; Editing by Sandra Maler)

Read more

Fitch Maintains Cigna's Ratings on Watch Negative

(The following statement was released by the rating agency)

CHICAGO, January 18 (Fitch) Fitch Ratings has maintained the

Rating Watch

Negative on Cigna Corporation's (Cigna) 'A-' Issuer Default

Rating (IDR), 'BBB+'

senior unsecured notes and the 'A+' Insurer Financial Strength

(IFS) ratings of

certain subsidiaries.

Today's action follows the completion of a periodic review of

Cigna's ratings,

which have been on a Negative Watch since July 24, 2015

following the

announcement of a definitive

Read more

BRIEF-Mallinckrodt responds to media reports regarding previously disclosed FTC investigation

* Mallinckrodt responds to media reports regarding

previously disclosed FTC investigation

Read more

EU mergers and takeovers (Jan 18)

BRUSSELS, Jan 18 (Reuters) - The following are mergers under

review by the European Commission and a brief guide to the EU

merger process:

Read more